Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide

Retrieved on: 2021-05-27 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide. View article details on hiswai:

Excerpt

Jeito selects Pulmocide as its fourth investment since launching the fund; Pulmocide is a late-stage biopharma company focused on the development ...

Article found on: www.globenewswire.com